Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Karen E. Malone"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background Rhizomelic chondrodysplasia punctata (RCDP) is an inherited ultra-rare disease which results in severely impaired physical and mental development. Mutations in one of five genes involved in plasmalogen biosynthesis have been repor
Externí odkaz:
https://doaj.org/article/a4aa68993920432aa840c0b0466ef63d
Autor:
Hendrika W. Grievink, Silvana M. G. Jirka, Tess D. Woutman, Mascha Schoonakker, Robert Rissmann, Karen E. Malone, Gary Feiss, Matthijs Moerland
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 5, Pp 891-895 (2020)
LL‐37 is a cationic antimicrobial peptide and the sole human member of cathelicidins. Besides its bactericidal properties, LL‐37 is known to have direct immunomodulatory effects, among which enhancement of antiviral responses via endosomal toll
Externí odkaz:
https://doaj.org/article/f3c81ec86b354db9bc8ac7829c51fcef
Autor:
Karen E. Malone, Matthijs Moerland, Silvana M.G. Jirka, Tess D. Woutman, G. Feiss, Hendrika W. Grievink, Robert Rissmann, Mascha Schoonakker
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 13, Iss 5, Pp 891-895 (2020)
Clinical and Translational Science, 13(5), 891-895. WILEY
Clinical and Translational Science, Vol 13, Iss 5, Pp 891-895 (2020)
Clinical and Translational Science, 13(5), 891-895. WILEY
LL-37 is a cationic antimicrobial peptide and the sole human member of cathelicidins. Besides its bactericidal properties, LL-37 is known to have direct immunomodulatory effects, among which enhancement of antiviral responses via endosomal toll-like
Autor:
Joannes A. A. Reijers, Richard Verbeek, Jacobus Burggraaf, Matthijs Moerland, Jeffrey J. Bajramovic, Karen E. Malone
Publikováno v:
British Journal of Clinical Pharmacology
Drug safety is an important issue, especially in the experimental phases of development. Adverse immunostimulation (AI) is sometimes encountered following treatment with biopharmaceuticals, which can be life-threatening if it results in a severe syst
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Background Rhizomelic chondrodysplasia punctata (RCDP) is an inherited ultra-rare disease which results in severely impaired physical and mental development. Mutations in one of five genes involved in plasmalogen biosynthesis have been reported to dr
Autor:
Matthijs Moerland, Karen E. Malone, Erik S.G. Stroes, Marleen Kemper, Jacobus Burggraaf, Marieke de Kam, Marlous R. Dillingh, Eveline P. van Poelgeest
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 89:39-46
Introduction: Although the effects of relatively high concentrations of endotoxin on endothelial activation/dysfunction and kidney markers has been described in literature, detailed insight in the LPS concentration-effect relationship, the magnitude,
Autor:
Matthijs Moerland, Jacobus Burggraaf, Dimitar Tasev, Karen E. Malone, Hendrika W. Grievink, Cornelis Kluft, Thi Anh Thu Tran, Katarzyna Lipinska
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 4, p e0214999 (2019)
PLoS ONE, Vol 14, Iss 4, p e0214999 (2019)
Processing of pro-interleukin (IL)-1β and IL-18 is regulated by multiprotein complexes, known as inflammasomes. Inflammasome activation results in generation of bioactive IL-1β and IL-18, which can exert potent pro-inflammatory effects. Our aim was
Publikováno v:
Biopreservation and Biobanking. 14:410-415
Routine techniques for the isolation of human peripheral blood mononuclear cells (PBMCs) include density centrifugation with Ficoll-Paque and isolation by cell preparation tubes (CPTs) and SepMate tubes with Lymphoprep. In a series of experiments, th
Autor:
Matthijs Moerland, Joannes A. A. Reijers, David Kallend, J. Burggraaf, Peter L.J. Wijngaard, Johan Wouter Jukema, Karen E. Malone
Publikováno v:
Cardiovascular Drugs and Therapy
Cardiovascular Drugs and Therapy, 31(4), 381-389
Cardiovascular Drugs and Therapy, 31(4), 381-389
Purpose Aim of this study was to demonstrate that MDCO-216 (human recombinant Apolipoprotein A-I Milano) does not induce adverse immunostimulation, in contrast to its predecessor, ETC-216, which was thought to contain host cell proteins (HCPs) that e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc959458f237293ef5178c3986e87b95
https://hdl.handle.net/1887/95096
https://hdl.handle.net/1887/95096
Autor:
Claudia Rehrig, Jacobus Burggraaf, Joannes A. A. Reijers, Matthijs Moerland, Karen E. Malone, Liz Yamashita, Kenneth Bahrt, Marlous R. Dillingh
Publikováno v:
Frontiers in Immunology. 7
ONS-3010 is being developed by Oncobiologics Inc. (Cranbury, NJ, USA) as a biosimilar of Humira®. This randomized, double blind, single-center phase I study (EudraCT registration # 2013-003551-38) was performed to demonstrate pharmacokinetic (PK) bi